SRGN Antibody (1D8)

This product is produced by and distributed for Abnova, a company based in Taiwan.

This gene encodes a protein best known as a hematopoietic cell granule proteoglycan. Proteoglycans stored in the secretory granules of many hematopoietic cells also contain a protease-resistant peptide core, which may be important for neutralizing hydrolytic enzymes. This encoded protein was found to be associated with the macromolecular complex of granzymes and perforin, which may serve as a mediator of granule-mediated apoptosis. [provided by RefSeq]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 4 of 4.

Publications using H00005552-M03	Applications	Species
Chu Q, Huang H, Huang T et al. Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/beta-catenin axis. Cell Death Dis 2016-11-03 [PMID: 27809309]
Reine TM, Vuong TT, Jenssen TG, Kolset SO. Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro. Biochim Biophys Acta. 2014-02-07 [PMID: 24513305]
Gasimli L, Hickey AM, Yang B et al. Changes in glycosaminoglycan structure on differentiation of human embryonic stem cells towards mesoderm and endoderm lineages. BBA General Subjects. 2014-01-01 [PMID: 24412195]
Li XJ, Ong CK, Cao Y et al. Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res. 2011-02-02 [PMID: 21289131]

Array H00005552-M03

• SRGN Antibodies
• SRGN ELISA Kits
• SRGN Lysate
• SRGN Proteins
• SRGN Proteins and Enzyme